A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-finding Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects with Non-alcoholic Steatohepatitis (NASH) and Stage 3 or Stage 4 Liver Fibrosis

Project: Research

StatusActive
Effective start/end date19/12/1931/12/24

Keywords

  • Non-alcoholic steatohepatitis
  • Liver fibrosis
  • Clinical trial